BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8295006)

  • 1. Discriminated release of a hippurate-like radiometal chelate in nontarget tissues for target-selective radioactivity localization using pH-dependent dissociation of reduced antibody.
    Arano Y; Inoue T; Mukai T; Wakisaka K; Sakahara H; Konishi J; Yokoyama A
    J Nucl Med; 1994 Feb; 35(2):326-33. PubMed ID: 8295006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A newly designed radioimmunoconjugate releasing a hippurate-like radiometal chelate for enhanced target/non-target radioactivity.
    Arano Y; Matsushima H; Tagawa M; Inoue T; Koizumi M; Hosono M; Sakahara H; Endo K; Konishi J; Yokoyama A
    Nucl Med Biol; 1994 Jan; 21(1):63-9. PubMed ID: 9234265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
    Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
    Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel bifunctional metabolizable linker for the conjugation of antibodies with radionuclides.
    Arano Y; Matsushima H; Tagawa M; Koizumi M; Endo K; Konishi J; Yokoyama A
    Bioconjug Chem; 1991; 2(2):71-6. PubMed ID: 1868115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of a metabolizable ester bond in radioimmunoconjugates.
    Arano Y; Wakisaka K; Mukai T; Uezono T; Motonari H; Akizawa H; Kairiyama C; Ohmomo Y; Tanaka C; Ishiyama M; Sakahara H; Konishi J; Yokoyama A
    Nucl Med Biol; 1996 Feb; 23(2):129-36. PubMed ID: 8868284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the radiochemical design of antibodies with a metabolizable linkage for target-selective radioactivity delivery.
    Arano Y; Wakisaka K; Akizawa H; Ono M; Kawai K; Nakayama M; Sakahara H; Konishi J; Saji H
    Bioconjug Chem; 1998; 9(4):497-506. PubMed ID: 9667952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maleimidoethyl 3-(tri-n-butylstannyl)hippurate: a useful radioiodination reagent for protein radiopharmaceuticals to enhance target selective radioactivity localization.
    Arano Y; Wakisaka K; Ohmomo Y; Uezono T; Mukai T; Motonari H; Shiono H; Sakahara H; Konishi J; Tanaka C
    J Med Chem; 1994 Aug; 37(16):2609-18. PubMed ID: 8057303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
    Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
    Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a "chase" without decreased accumulation in the target tumor.
    Kobayashi H; Sakahara H; Hosono M; Yao ZS; Toyama S; Endo K; Konishi J
    J Nucl Med; 1994 Oct; 35(10):1677-84. PubMed ID: 7931671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of free radionuclide by a chelating agent improves tumor-to-nontumor ratios following radioimmunotargeting with antibody labeled with 67Ga.
    Ryser JE; Rose K; Jones R; Pelegrin A; Donath A; Egeli R; Smith A; Offord RE
    Nucl Med Biol; 1998 Apr; 25(3):261-5. PubMed ID: 9620632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 67Ga-labeled antibodies for immunoscintigraphy and evaluation of tumor targeting of drug-antibody conjugates in mice.
    Koizumi M; Endo K; Kunimatsu M; Sakahara H; Nakashima T; Kawamura Y; Watanabe Y; Saga T; Konishi J; Yamamuro T
    Cancer Res; 1988 Mar; 48(5):1189-94. PubMed ID: 3422590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo instability of reduction-mediated 99mTc-labeled monoclonal antibody.
    Sakahara H; Saga T; Endo K; Hattori N; Hosono M; Kobayashi H; Shirato M; Yamamuro T; Toyama S; Arano Y
    Nucl Med Biol; 1993 Jul; 20(5):617-23. PubMed ID: 8358347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Labeling of monoclonal antibodies with a 67Ga-phenolic aminocarboxylic acid chelate. Part II. Comparison of immunoreactivity and biodistribution of monoclonal antibodies labeled with the 67Ga-chelate or with 131I.
    Matzku S; Schuhmacher J; Kirchgessner H; Brüggen J
    Eur J Nucl Med; 1986; 12(8):405-12. PubMed ID: 3792375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo radiolocalization of antiosteogenic sarcoma monoclonal antibodies in osteogenic sarcoma xenografts.
    Nakamura T; Sakahara H; Hosoi S; Yamamuro T; Higashi S; Mikawa H; Endo K; Toyama S
    Cancer Res; 1984 May; 44(5):2078-83. PubMed ID: 6585270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and characterization of monoclonal antibodies against an octahedral gallium chelate suitable for immunoscintigraphy with PET.
    Zöller M; Schuhmacher J; Reed J; Maier-Borst W; Matzku S
    J Nucl Med; 1992 Jul; 33(7):1366-72. PubMed ID: 1613579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of 67Ga-labeled antibodies using deferoxamine as a bifunctional chelate. An improved method.
    Koizumi M; Endo K; Kunimatsu M; Sakahara H; Nakashima T; Kawamura Y; Watanabe Y; Ohmomo Y; Arano Y; Yokoyama A
    J Immunol Methods; 1987 Nov; 104(1-2):93-102. PubMed ID: 3316401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics.
    van Gog FB; Visser GW; Klok R; van der Schors R; Snow GB; van Dongen GA
    J Nucl Med; 1996 Feb; 37(2):352-62. PubMed ID: 8667076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multistep tumor targeting in nude mice using bispecific antibodies and a gallium chelate suitable for immunoscintigraphy with positron emission tomography.
    Schuhmacher J; Klivényi G; Matys R; Stadler M; Regiert T; Hauser H; Doll J; Maier-Borst W; Zöller M
    Cancer Res; 1995 Jan; 55(1):115-23. PubMed ID: 7805020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of human osteogenic sarcoma xenografts in nude mice by a monoclonal antibody labeled with radioiodine and indium-111.
    Sakahara H; Endo K; Nakashima T; Koizumi M; Kunimatsu M; Kawamura Y; Ohta H; Nakamura T; Tanaka H; Kotoura Y
    J Nucl Med; 1987 Mar; 28(3):342-8. PubMed ID: 3469333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of internally labeled monoclonal antibodies as a gold standard: comparison of biodistribution of 75Se-, 111In-, and 125I-labeled monoclonal antibodies in osteogenic sarcoma xenografts in nude mice.
    Koizumi M; Endo K; Watanabe Y; Saga T; Sakahara H; Konishi J; Yamamuro T; Toyama S
    Cancer Res; 1989 Apr; 49(7):1752-7. PubMed ID: 2924318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.